Cholesterol, diabetes and major cardiovascular diseases in the Asia-Pacific region (Q46971473)

27 December 2017

title

Cholesterol, diabetes and major cardiovascular diseases in the Asia-Pacific region (English)

1 reference

27 December 2017

main subject

cardiovascular disease

1 reference

inferred from title

author name string

Asia Pacific Cohort Studies Collaboration

series ordinal

1

1 reference

27 December 2017

publication date

25 September 2007

1 reference

27 December 2017

published in

Diabetologia

1 reference

27 December 2017

volume

50

1 reference

27 December 2017

page(s)

2289-2297

1 reference

27 December 2017

issue

11

1 reference

27 December 2017

https://scigraph.springernature.com/pub.10.1007/s00125-007-0801-2

exact match

0 references

cites work

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

12 December 2020

Cholesterol, coronary heart disease, and stroke in the Asia Pacific region

1 reference

12 December 2020

Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials

1 reference

12 December 2020

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

12 December 2020

High-dose atorvastatin after stroke or transient ischemic attack

1 reference

12 December 2020

Incidence and trends of stroke and its subtypes in China: results from three large cities

1 reference

12 December 2020

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

12 December 2020

Proportion of different subtypes of stroke in China

1 reference

12 December 2020

Trends in the incidence of coronary heart disease and stroke and the prevalence of cardiovascular risk factors among Japanese men from 1963 to 1994.

1 reference

12 December 2020

Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study

1 reference

12 December 2020

Diabetes and cardiovascular risk factors: the Framingham study

1 reference

12 December 2020

Cardiovascular mortality in Korea: a country experiencing epidemiologic transition.

1 reference

12 December 2020

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

12 December 2020

Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes

1 reference

12 December 2020

Diabetes and atherosclerosis: an epidemiologic view

1 reference

12 December 2020

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

1 reference

12 December 2020

Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status

1 reference

12 December 2020

Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999

1 reference

12 December 2020

Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group

1 reference

12 December 2020

Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: implication from Japan Lipid Intervention Trial (J-LIT).

1 reference

12 December 2020

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

12 December 2020

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

12 December 2020

The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region.

1 reference

12 December 2020

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

12 December 2020

10.1007/S00125-007-0801-2

Identifiers

DOI

1 reference

27 December 2017

PubMed ID

17909878

1 reference

27 December 2017